Developer docs
API playgroundTry for free, no card

Search company profiles

BoomRx

Full company profile

uuid00q5mcp

Namestring
BoomRx
Legal namestring
Click to Fill, Inc.
Websiteurl
boomrx.com
Company typeenum
Private
Founded yearint
2025
Descriptiontext

BoomRx is a US-based pharmacy technology platform launched in July 2025 under parent company WellSync that aggregates prescription sourcing and fulfillment for medical clinics, telehealth operators, med spas, and wellness practices. The company consolidates licensed 503A compounding pharmacies and FDA-registered 503B outsourcing facilities behind a single secure portal, replacing the multi-vendor pharmacy relationships that historically consumed 10–20+ staff hours per week at prescribing clinics. The legal operating entity is Click to Fill, Inc., incorporated in Delaware, with Tampa, Florida as its commercial headquarters.

The core product is a centralized pharmacy portal featuring real-time order tracking, automated patient SMS delivery notifications, transparent in-platform pricing, and EMR integration via REST API plus an embeddable JavaScript ordering module. A proprietary nanoemulsion delivery technology has been applied to oral formulations of semaglutide, tirzepatide, testosterone, and PDE5-inhibitor combination erectile dysfunction therapy, supporting injection-free prescribing across weight loss, hormone replacement, and sexual health. 503B partners provide sterile injectables with extended 90/180/365-day Beyond-Use Dates, and shipments are handled under a flat $30 cold-chain rate to all 50 states and U.S. territories.

Revenue is generated transactionally through per-prescription fulfillment fees plus the flat shipping charge, with claimed pricing approximately 20% below industry averages. Distribution is direct, combining consultative field sales for enterprise telehealth operators with a self-serve web portal and API/EMR integration for multi-location practices. By June 2026, the platform reported more than 4,500 clinics, 40,000+ orders per month at 20% month-over-month growth, an 85% clinic reorder rate, a 2.4% refund rate, and a $70M+ annualized run rate. No third-party institutional funding rounds are disclosed; the company is privately held as a WellSync subsidiary.

Short descriptiontext

BoomRx is a US pharmacy technology platform that aggregates 503A compounding and FDA-registered 503B outsourcing pharmacies into a single fulfillment portal for medical clinics, telehealth operators, med spas, and wellness practices, serving 4,500+ clinics nationwide with proprietary nanoemulsion delivery formulations.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersGainesville, United States
HQ citystring
Gainesville
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmacy fulfillment platform, compounding pharmacy access, prescription sourcing software, telehealth pharmacy integration, medical clinic pharmacy portal
Industry4 codes
PRIMARYHLACAKAG
Specialty Pharmacy & Complex Therapy Management Platforms
Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT
SECONDARYHLACAKAM
Compounding Pharmacy & Sterile Prep Workflow Systems
Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT
SECONDARYHLACAPAH
Medication Adherence & Smart Drug Delivery (Connected Inhalers, Pens, Pill Dispensers)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLALAIAG
Medication Adherence & Therapy Management Platforms (refills, reminders, MTM)
Healthcare & Life Sciences/Telehealth Platforms/Pharmacy-Integrated Telehealth & ePrescribing Platforms
NAICS code1 code
  • Drugs and Druggists' Sundries Merchant Wholesalers42421
SIC code2 codes
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
  • Pharmaceutical Preparations2834
Product category
Pharmacy Fulfillment Software
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Prescription Fulfillment Services
TypeTransaction Fee
Description

BoomRx generates revenue through prescription order processing and fulfillment services to medical clinics and healthcare providers. The platform connects clinics to its pharmacy network and coordinates fulfillment, charging competitive industry pricing with transparent platform pricing and a flat $30 shipping fee. Revenue has grown from $15.5M net order revenue in first 8 months to over $70M annualized run rate.

boomrx.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details2 tiers
1Transparent pricing with competitive rates
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Best industry pricing — 20% less cost on average. Single $30 flat fee cold chain shipping. Pricing displayed within the platform for clear visibility.

boomrx.com
2One consolidated shipping fee
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$30 flat fee cold chain shipping replaces variable multi-pharmacy shipping fees. Single consolidated flat shipping rate across all orders.

boomrx.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

BoomRx operates a centralized pharmacy portal platform that consolidates prescription sourcing, ordering, and fulfillment across 503A compounding pharmacies, FDA-registered 503B outsourcing facilities, and brand medications through a single secure interface for medical clinics, med spas, telehealth providers, and physician offices. The platform provides 50-state cold chain shipping with a flat $30 fee, real-time order tracking, EMR API integration, automated SMS patient updates, and access to 300+ therapies covering weight loss, peptides, TRT, BHRT, erectile dysfunction, hair loss, and dermatology. The company also applies proprietary nanoemulsion delivery technology to oral formulations of semaglutide, tirzepatide, testosterone, and erectile dysfunction medications.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 90%+ reduction in prescription management administrative time
+5 more records
Product overview1 text field

BoomRx is a unified pharmacy technology platform that consolidates prescription sourcing and fulfillment for medical practices, functioning as a single portal replacing multiple pharmacy relationships. The platform provides access to 503A compounding pharmacies, FDA-registered 503B outsourcing facilities, and brand medications through one secure interface. The core offering includes the BoomRx Pharmacy Portal with real-time order tracking and EMR integration capabilities, supporting therapeutic areas including hormone therapy (injectable, topical, and oral HRT/TRT), sexual health (ED therapies), weight management (GLP-1, peptide-based protocols, and oral nanoemulsion medications), peptides and longevity, hair and skin treatments, and general wellness. Add-on modules include oral nanoemulsion formulations of semaglutide, tirzepatide, testosterone, and erectile dysfunction therapies, plus peptide-based skincare products. The platform offers $30 flat-rate cold chain shipping to all 50 states and competitive pricing (20% below industry average).

Product and service6 records
1BoomRx Pharmacy Portal
CategoryPharmacy Fulfillment Platform
Description

Unified prescription sourcing and fulfillment platform consolidating multiple pharmacy relationships, portals, and workflows into a single secure interface for physician practices, med spas, telemedicine providers, and wellness clinics. Provides access to 503A compounding pharmacies, FDA-registered 503B outsourcing facilities, and brand medications with 50-state shipping.

2Oral Semaglutide
CategoryWeight Management Medication
Description

Oral weight management medication utilizing proprietary nanoemulsion delivery technology for enhanced absorption and consistent dosing in GLP-1 based weight loss protocols, available to medical clinics, med spas, wellness practices, and telemedicine providers nationwide.

3Oral Tirzepatide
CategoryWeight Management Medication
Description

Oral weight management medication utilizing proprietary nanoemulsion delivery technology for enhanced absorption and dose uniformity in GIP/GLP-1 based weight loss protocols, available nationwide for medical clinics, med spas, wellness practices, and telemedicine providers.

4Oral Liquid Testosterone Replacement Therapy (TRT)
CategoryHormone Replacement Therapy Medication
Description

Injection-free oral liquid testosterone replacement therapy using proprietary nanoemulsion delivery, designed to support telemedicine, med spa, and hybrid practices in expanding TRT services without in-office administration burden.

5Oral Liquid Erectile Dysfunction Therapy
CategorySexual Health Medication
Description

Oral liquid erectile dysfunction therapy combining sildenafil, tadalafil, and vardenafil (PDE5 inhibitors) in a proprietary nanoemulsion delivery system, providing an injection-free option for men's sexual health treatment as part of comprehensive wellness care.

6Copper Peptide Skin Repair Cream
CategoryDermatology Skincare Product
Description

Peptide-based skincare product centered on GHK-Cu (Copper Tripeptide-1), supporting skin repair, smoother texture, improved firmness, and appearance of youthful, collagen-rich skin. Enables healthcare providers to integrate aesthetic skincare alongside existing therapies.

Scale indicator12 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierSupportingTypeTechnology or Integration
Description

BoomRx's platform users are bound by Google's Terms of Service. The platform uses Google Maps API(s) for location services, with further information available in Google's Privacy Policy.

2503A Compounding Pharmacies
Strategic tierCoreTypeTechnology or Integration
Description

BoomRx partners with licensed 503A compounding pharmacies operating under section 503A of the Federal Food, Drug, and Cosmetic Act. These pharmacies provide access to compounded preparations for weight management, hormone therapy, peptides, and specialty medications through the centralized portal.

boomrx.com
Strategic tierCoreTypeTechnology or Integration
Description

BoomRx partners with FDA-registered 503B outsourcing facilities subject to current Good Manufacturing Practice (cGMP) requirements and FDA inspection. These facilities provide injectable sterile medications with extended Beyond-Use Dates (90, 180, 365 days), supporting longer patient programs and reduced shipping frequency.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
1Ro
TypeBroad incumbent
Description

Telehealth platform with vertically integrated pharmacy operations covering weight management, men's health, and dermatology. Comparable in therapeutic overlap and as a potential consolidator building its own practitioner and pharmacy rails.

TypeBroad incumbent
Description

ePrescribing platform integrated into numerous EMR systems, enabling controlled substance and general prescribing workflows for clinicians. Comparable on the EMR integration and ePrescribing layer, though DoseSpot is workflow rather than fulfillment.

TypeDirect peer
Description

Practitioner-facing wellness and pharmacy platform serving integrative and functional medicine clinics with prescription and supplement fulfillment. Directly comparable as a B2B portal aggregating dispensing partners for clinics, though Fullscript leans more toward supplements than compounding pharmacy.

TypeDirect peer
Description

Digital-first pharmacy offering integrated EMR-style ordering and tracking for providers with home delivery to patients. Comparable technology-forward pharmacy model, though consumer-direct rather than B2B clinic portal.

TypeDirect peer
Description

Digital pharmacy platform with same-day delivery, real-time tracking, and EMR-integrated ordering for providers and patients. Comparable as a technology-forward pharmacy aggregator, though Alto is consumer-direct rather than practitioner-portal-first like BoomRx.

TypeDirect peer
Description

Large 503A and 503B compounding pharmacy serving practitioners nationwide with weight loss, hormone, and peptide therapies. Comparable as a major supplier in the same compounding categories BoomRx aggregates, with overlapping customer base of med spas, telehealth, and clinics.

TypeDirect peer
Description

Compounding pharmacy network providing customized medications for clinics, med spas, and telehealth providers across multiple states. Closely comparable business model as a multi-state compounder serving the same practitioner segments BoomRx targets.

TypeDirect peer
Description

National compounding pharmacy network (503A) serving integrative, functional, and anti-aging practitioners with hormone and peptide therapies. Directly comparable as a multi-state compounder targeting the same med spa, wellness, and telehealth customer base.

TypeDirect peer
Description

503A and 503B compounding pharmacy specializing in sterile injectables, hormones, and wellness therapies for practitioners. Comparable as a 503B outsourcing facility serving clinics and med spas in categories BoomRx aggregates.

TypeBroad incumbent
Description

Vertically integrated telehealth and pharmacy platform offering weight loss, TRT, ED, and dermatology direct to consumers. Operates in overlapping therapeutic categories and could become a competitor or potential acquirer as it builds practitioner and compounding capabilities.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

BoomRx

Pharmacy Fulfillment Softwareboomrx.com

BoomRx is a US pharmacy technology platform that aggregates 503A compounding and FDA-registered 503B outsourcing pharmacies into a single fulfillment portal for medical clinics, telehealth operators, med spas, and wellness practices, serving 4,500+ clinics nationwide with proprietary nanoemulsion delivery formulations.

What BoomRx does

BoomRx is a US-based pharmacy technology platform launched in July 2025 under parent company WellSync that aggregates prescription sourcing and fulfillment for medical clinics, telehealth operators, med spas, and wellness practices. The company consolidates licensed 503A compounding pharmacies and FDA-registered 503B outsourcing facilities behind a single secure portal, replacing the multi-vendor pharmacy relationships that historically consumed 10–20+ staff hours per week at prescribing clinics. The legal operating entity is Click to Fill, Inc., incorporated in Delaware, with Tampa, Florida as its commercial headquarters.

The core product is a centralized pharmacy portal featuring real-time order tracking, automated patient SMS delivery notifications, transparent in-platform pricing, and EMR integration via REST API plus an embeddable JavaScript ordering module. A proprietary nanoemulsion delivery technology has been applied to oral formulations of semaglutide, tirzepatide, testosterone, and PDE5-inhibitor combination erectile dysfunction therapy, supporting injection-free prescribing across weight loss, hormone replacement, and sexual health. 503B partners provide sterile injectables with extended 90/180/365-day Beyond-Use Dates, and shipments are handled under a flat $30 cold-chain rate to all 50 states and U.S. territories.

Revenue is generated transactionally through per-prescription fulfillment fees plus the flat shipping charge, with claimed pricing approximately 20% below industry averages. Distribution is direct, combining consultative field sales for enterprise telehealth operators with a self-serve web portal and API/EMR integration for multi-location practices. By June 2026, the platform reported more than 4,500 clinics, 40,000+ orders per month at 20% month-over-month growth, an 85% clinic reorder rate, a 2.4% refund rate, and a $70M+ annualized run rate. No third-party institutional funding rounds are disclosed; the company is privately held as a WellSync subsidiary.

BoomRx firmographics

Firmographics
Name
BoomRx
Legal name
Click to Fill, Inc.
Website
https://boomrx.com
Company type
Private
Founded year
2025
Operating status
Operating
Headcount range
51–100 employees
Short description
BoomRx is a US pharmacy technology platform that aggregates 503A compounding and FDA-registered 503B outsourcing pharmacies into a single fulfillment portal for medical clinics, telehealth operators, med spas, and wellness practices, serving 4,500+ clinics nationwide with proprietary nanoemulsion delivery formulations.
Ownership category
akta.pro rank

BoomRx industry classification

Industry
Product category
Pharmacy Fulfillment Software
NAICS
Drugs and Druggists' Sundries Merchant Wholesalers (42421)
SIC
Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYHLACAKAG
Specialty Pharmacy & Complex Therapy Management Platforms
Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT
SECONDARYHLACAKAM
Compounding Pharmacy & Sterile Prep Workflow Systems
Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT
SECONDARYHLACAPAH
Medication Adherence & Smart Drug Delivery (Connected Inhalers, Pens, Pill Dispensers)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLALAIAG
Medication Adherence & Therapy Management Platforms (refills, reminders, MTM)
Healthcare & Life Sciences/Telehealth Platforms/Pharmacy-Integrated Telehealth & ePrescribing Platforms

Keywords

  • Pharmacy fulfillment platform
  • Compounding pharmacy access
  • Prescription sourcing software
  • Telehealth pharmacy integration
  • Medical clinic pharmacy portal

Where BoomRx is headquartered

Location

Headquarters

HQ city
Gainesville
HQ country
United States
HQ region
North America

Offices2 records

Markets served

BoomRx business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Prescription Fulfillment Services: BoomRx generates revenue through prescription order processing and fulfillment services to medical clinics and healthcare providers. The platform connects clinics to its pharmacy network and coordinates fulfillment, charging competitive industry pricing with transparent platform pricing and a flat $30 shipping fee. Revenue has grown from $15.5M net order revenue in first 8 months to over $70M annualized run rate.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goTransparent pricing with competitive rates
Unit PricingPay-as-you-goOne consolidated shipping fee

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

BoomRx product offering

Product offering

Core offering

BoomRx operates a centralized pharmacy portal platform that consolidates prescription sourcing, ordering, and fulfillment across 503A compounding pharmacies, FDA-registered 503B outsourcing facilities, and brand medications through a single secure interface for medical clinics, med spas, telehealth providers, and physician offices. The platform provides 50-state cold chain shipping with a flat $30 fee, real-time order tracking, EMR API integration, automated SMS patient updates, and access to 300+ therapies covering weight loss, peptides, TRT, BHRT, erectile dysfunction, hair loss, and dermatology. The company also applies proprietary nanoemulsion delivery technology to oral formulations of semaglutide, tirzepatide, testosterone, and erectile dysfunction medications.

Product overview

BoomRx is a unified pharmacy technology platform that consolidates prescription sourcing and fulfillment for medical practices, functioning as a single portal replacing multiple pharmacy relationships. The platform provides access to 503A compounding pharmacies, FDA-registered 503B outsourcing facilities, and brand medications through one secure interface. The core offering includes the BoomRx Pharmacy Portal with real-time order tracking and EMR integration capabilities, supporting therapeutic areas including hormone therapy (injectable, topical, and oral HRT/TRT), sexual health (ED therapies), weight management (GLP-1, peptide-based protocols, and oral nanoemulsion medications), peptides and longevity, hair and skin treatments, and general wellness. Add-on modules include oral nanoemulsion formulations of semaglutide, tirzepatide, testosterone, and erectile dysfunction therapies, plus peptide-based skincare products. The platform offers $30 flat-rate cold chain shipping to all 50 states and competitive pricing (20% below industry average).

Differentiator

Problem solved

Functional benefit

Products and services

  • BoomRx Pharmacy Portal Unified prescription sourcing and fulfillment platform consolidating multiple pharmacy relationships, portals, and workflows into a single secure interface for physician practices, med spas, telemedicine providers, and wellness clinics. Provides access to 503A compounding pharmacies, FDA-registered 503B outsourcing facilities, and brand medications with 50-state shipping.
  • Oral Semaglutide Oral weight management medication utilizing proprietary nanoemulsion delivery technology for enhanced absorption and consistent dosing in GLP-1 based weight loss protocols, available to medical clinics, med spas, wellness practices, and telemedicine providers nationwide.
  • Oral Tirzepatide Oral weight management medication utilizing proprietary nanoemulsion delivery technology for enhanced absorption and dose uniformity in GIP/GLP-1 based weight loss protocols, available nationwide for medical clinics, med spas, wellness practices, and telemedicine providers.
  • Oral Liquid Testosterone Replacement Therapy (TRT) Injection-free oral liquid testosterone replacement therapy using proprietary nanoemulsion delivery, designed to support telemedicine, med spa, and hybrid practices in expanding TRT services without in-office administration burden.
  • Oral Liquid Erectile Dysfunction Therapy Oral liquid erectile dysfunction therapy combining sildenafil, tadalafil, and vardenafil (PDE5 inhibitors) in a proprietary nanoemulsion delivery system, providing an injection-free option for men's sexual health treatment as part of comprehensive wellness care.
  • Copper Peptide Skin Repair Cream Peptide-based skincare product centered on GHK-Cu (Copper Tripeptide-1), supporting skin repair, smoother texture, improved firmness, and appearance of youthful, collagen-rich skin. Enables healthcare providers to integrate aesthetic skincare alongside existing therapies.

Quantifiable outcome

  • 90%+ reduction in prescription management administrative time
  • +5 more outcomes

Companies that use BoomRx

Customer profile

Named customers2 records

Segments5 records

Ideal customer profiles4 records

BoomRx technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

Feature6 records

BoomRx partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered supporting and core.

  • GooglesupportingTechnology or IntegrationBoomRx's platform users are bound by Google's Terms of Service. The platform uses Google Maps API(s) for location services, with further information available in Google's Privacy Policy.
  • 503A Compounding PharmaciescoreTechnology or IntegrationBoomRx partners with licensed 503A compounding pharmacies operating under section 503A of the Federal Food, Drug, and Cosmetic Act. These pharmacies provide access to compounded preparations for weight management, hormone therapy, peptides, and specialty medications through the centralized portal.
  • 503B Outsourcing FacilitiescoreTechnology or IntegrationBoomRx partners with FDA-registered 503B outsourcing facilities subject to current Good Manufacturing Practice (cGMP) requirements and FDA inspection. These facilities provide injectable sterile medications with extended Beyond-Use Dates (90, 180, 365 days), supporting longer patient programs and reduced shipping frequency.

Scale indicators12 records

Recent moves6 records

Expansion highlights4 records

BoomRx competitors and assessment

Company assessment

Broad incumbents

  • Ro: Telehealth platform with vertically integrated pharmacy operations covering weight management, men's health, and dermatology. Comparable in therapeutic overlap and as a potential consolidator building its own practitioner and pharmacy rails.
  • DoseSpot: ePrescribing platform integrated into numerous EMR systems, enabling controlled substance and general prescribing workflows for clinicians. Comparable on the EMR integration and ePrescribing layer, though DoseSpot is workflow rather than fulfillment.
  • Hims & Hers Health: Vertically integrated telehealth and pharmacy platform offering weight loss, TRT, ED, and dermatology direct to consumers. Operates in overlapping therapeutic categories and could become a competitor or potential acquirer as it builds practitioner and compounding capabilities.

Direct peers

  • Fullscript: Practitioner-facing wellness and pharmacy platform serving integrative and functional medicine clinics with prescription and supplement fulfillment. Directly comparable as a B2B portal aggregating dispensing partners for clinics, though Fullscript leans more toward supplements than compounding pharmacy.
  • Capsule Pharmacy: Digital-first pharmacy offering integrated EMR-style ordering and tracking for providers with home delivery to patients. Comparable technology-forward pharmacy model, though consumer-direct rather than B2B clinic portal.
  • Alto Pharmacy: Digital pharmacy platform with same-day delivery, real-time tracking, and EMR-integrated ordering for providers and patients. Comparable as a technology-forward pharmacy aggregator, though Alto is consumer-direct rather than practitioner-portal-first like BoomRx.
  • Empower Pharmacy: Large 503A and 503B compounding pharmacy serving practitioners nationwide with weight loss, hormone, and peptide therapies. Comparable as a major supplier in the same compounding categories BoomRx aggregates, with overlapping customer base of med spas, telehealth, and clinics.
  • SMP Pharmacy Solutions: Compounding pharmacy network providing customized medications for clinics, med spas, and telehealth providers across multiple states. Closely comparable business model as a multi-state compounder serving the same practitioner segments BoomRx targets.
  • Belmar Pharma Solutions: National compounding pharmacy network (503A) serving integrative, functional, and anti-aging practitioners with hormone and peptide therapies. Directly comparable as a multi-state compounder targeting the same med spa, wellness, and telehealth customer base.
  • AnazaoHealth: 503A and 503B compounding pharmacy specializing in sterile injectables, hormones, and wellness therapies for practitioners. Comparable as a 503B outsourcing facility serving clinics and med spas in categories BoomRx aggregates.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

BoomRx social profiles

Digital presence

BoomRx compliance and trust

Trust signal

Compliance3 records

BoomRx financial estimates

Financial estimate

Revenue estimate

Valuation estimate

BoomRx leadership team

Management profile

Number of profiles

Profiles3 records

BoomRx funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

BoomRx M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BoomRx

What does BoomRx do?

BoomRx operates a centralized pharmacy portal platform that consolidates prescription sourcing, ordering, and fulfillment across 503A compounding pharmacies, FDA-registered 503B outsourcing facilities, and brand medications through a single secure interface for medical clinics, med spas, telehealth providers, and physician offices. The platform provides 50-state cold chain shipping with a flat $30 fee, real-time order tracking, EMR API integration, automated SMS patient updates, and access to 300+ therapies covering weight loss, peptides, TRT, BHRT, erectile dysfunction, hair loss, and dermatology. The company also applies proprietary nanoemulsion delivery technology to oral formulations of semaglutide, tirzepatide, testosterone, and erectile dysfunction medications.

Is BoomRx a public or private company?

BoomRx is a private company. It is classified as corporate owned and is currently operating.

When was BoomRx founded?

BoomRx was founded in 2025. It employs 51 to 100 people.

Where is BoomRx based?

BoomRx is headquartered in Gainesville, United States, in the North America region.

How does BoomRx make money?

One revenue line is on record: prescription Fulfillment Services.

Who are BoomRx's main competitors?

Broad incumbents on record are Ro, DoseSpot and Hims & Hers Health. Direct peers are Fullscript, Capsule Pharmacy, Alto Pharmacy, Empower Pharmacy, SMP Pharmacy Solutions, Belmar Pharma Solutions and AnazaoHealth.

Does BoomRx have an API?

Yes. BoomRx offers API integration that connects clinic EMR systems directly to the BoomRx pharmacy network, enabling automatic prescription order transmission, real-time status updates, and patient data synchronization without manual steps. Additionally, clinics can use a JavaScript module to embed a pre-built ordering interface into their systems.

What industry is BoomRx in?

BoomRx's product category is Pharmacy Fulfillment Software. Its primary akta.pro industry code is HLACAKAG, Specialty Pharmacy & Complex Therapy Management Platforms, with a secondary code of HLACAKAM, Compounding Pharmacy & Sterile Prep Workflow Systems. Its NAICS code is 42421 and its SIC code is 5122.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
EIN PresswireAesthetic Record and BoomRX Integrate to Simplify Medication Access for Aesthetic and Wellness PracticesAesthetic Record announced an integration with BoomRX, a pharmaceutical platform, to streamline medication access for aesthetic and wellness practices. The integration provides centralized ordering and fulfillment across 503A and 503B compounding pharmacies, reducing operational complexity. The companies aim to improve efficiency and support practice growth.EIN PresswireAesthetic Record and BoomRX Integrate to Simplify Medication Access for Aesthetic and Wellness PracticesAesthetic Record announced an integration with BoomRX, a pharmaceutical platform, to streamline medication access for aesthetic and wellness practices. The integration provides centralized ordering and fulfillment across 503A and 503B compounding pharmacies, aiming to reduce operational complexity.EIN PresswireBoomRx Puts Women’s Hormone Health in Focus With a Comprehensive Suite of Bioidentical HRT Options for PhysiciansBoomRx is highlighting its 24 bioidentical hormone-replacement therapies for women, including estrogen, progesterone, and DHEA, with multiple formulations. The company's pharmacy portal provides a single access point for healthcare providers to order and coordinate fulfillment. The platform supports clinics, OB-GYN practices, and telehealth organizations.AijournWellSync Reports Strong BoomRx Momentum with More Than $70-Million Annualized Run RateWellSync announced that its subsidiary BoomRx, a national pharmaceutical technology platform, has exceeded a $70-million annualized run rate since launching in July 2025, marking a key milestone for the company's digital healthcare ecosystem. The BoomRx platform is now used by more than 4,500 clinics across all 50 states, processing over 40,000 orders per month with 20-percent month-over-month growth and an 85-percent clinic return rate. The company cited growing demand for integrated virtual-care infrastructure, with the global telehealth market projected to expand from approximately $219 billion in 2026 to over $1.2 trillion by 2034.PR NewswireWellSync Reports Strong BoomRx Momentum with More Than $70-Million Annualized Run RateWellSync announced that its subsidiary BoomRx has exceeded a $70-million annualized run rate since launching in July 2025, establishing the platform as a flagship solution within WellSync's digital healthcare ecosystem. The BoomRx prescription-management platform now serves more than 4,500 clinics across all 50 states, processing over 40,000 orders per month with 20-percent month-over-month growth and an 85-percent clinic return rate. The milestone reflects growing demand for integrated virtual-care infrastructure as the global telehealth market is projected to expand from $219 billion in 2026 to over $1.2 trillion by 2034.PR NewswireBoomRx Introduces Peptide Skincare Line at A4M's Longevity SpringFest 2026BoomRx, a national pharmaceutical technology platform, announced the launch of a new peptide-based skincare line, with Copper Peptide Skin Repair Cream as the first product, debuting at the A4M Longevity SpringFest conference in West Palm Beach, Florida on April 11-12, 2026. The new portfolio allows healthcare providers to integrate aesthetic skincare treatments alongside existing therapies like hormone therapy and weight management through the same BoomRx pharmacy portal used for over 300 other therapies. CEO Kurt Lunkwitz stated the launch aims to expand what healthcare providers can offer patients without adding operational complexity, supported by nationwide shipping and centralized pharmacy coordination.PR NewswireBoomRx Expands Access to Peptide Therapies Through Centralized Pharmacy PortalBoomRx, a national pharmaceutical technology platform, announced the expansion of its centralized pharmacy portal to include peptide therapies for medical weight loss, hormone therapy, and clinical performance programs. The platform addresses growing demand for peptide-based treatments—the U.S. market is valued at $21 billion in 2025 and projected to reach nearly $35 billion by 2035—by consolidating sourcing and fulfillment into a single system to reduce administrative burden for medical practices. The company cited evolving regulatory frameworks around peptide compounding, noting that 19 peptides were effectively pushed outside routine compounding channels and the FDA is now reviewing whether 14 of those could return to regulated pharmaceutical supply chains.PR NewswireBoomRx Surpasses $15.5 Million in Net Order Revenue and 77,000+ Processed Orders in First Eight MonthsBoomRx announced it has surpassed $15.5 million in net order revenue and processed over 77,000 orders in its first eight months since launching in July 2025, with the platform now used by more than 1,750 medical clinics across all 50 states. The company reports strong operational metrics including more than 8,000 monthly orders, an 85 percent clinic return rate, and a 2.4 percent refund rate. BoomRx positions itself as addressing fragmented prescription sourcing by connecting clinic EMRs directly to its proprietary pharmacy network through API integration.BioSpaceBoomRx Surpasses $15.5 Million in Net Order Revenue and 77,000+ Processed Orders in First Eight MonthsBoomRx announced it has surpassed $15.5 million in net order revenue and processed more than 77,000 orders since launching in July 2025, with the platform now utilized by over 1,750 clinics across all 50 states and U.S. territories. The company reports averaging more than 8,000 orders per month with an 85 percent clinic return rate and a 2.4 percent refund rate, indicating strong repeat utilization. BoomRx plans to showcase its technology at the A4M Longevity Springfest 2026 in West Palm Beach, Florida.